302 related articles for article (PubMed ID: 9619420)
1. An inhibitor of the chymotrypsin-like activity of the proteasome (PSI) induces similar morphological changes in various cell lines.
Wójcik C
Folia Histochem Cytobiol; 1997; 35(4):211-4. PubMed ID: 9619420
[TBL] [Abstract][Full Text] [Related]
2. An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells.
Wójcik C; Schroeter D; Stoehr M; Wilk S; Paweletz N
Eur J Cell Biol; 1996 Jun; 70(2):172-8. PubMed ID: 8793390
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.
Wójcik C; Schroeter D; Wilk S; Lamprecht J; Paweletz N
Eur J Cell Biol; 1996 Nov; 71(3):311-8. PubMed ID: 8929570
[TBL] [Abstract][Full Text] [Related]
4. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo.
Fischer D; Gang G; Pritts T; Hasselgren PO
Biochem Biophys Res Commun; 2000 Apr; 270(1):215-21. PubMed ID: 10733930
[TBL] [Abstract][Full Text] [Related]
5. Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells.
Biały LP; Ziemba H; Pleban E; Wójcik C
Folia Histochem Cytobiol; 2002; 40(2):135-6. PubMed ID: 12056612
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides.
Lum RT; Nelson MG; Joly A; Horsma AG; Lee G; Meyer SM; Wick MM; Schow SR
Bioorg Med Chem Lett; 1998 Feb; 8(3):209-14. PubMed ID: 9871656
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiquitin chains.
Ohtani-Kaneko R; Takada K; Iigo M; Hara M; Yokosawa H; Kawashima S; Ohkawa K; Hirata K
Neurochem Res; 1998 Nov; 23(11):1435-43. PubMed ID: 9814555
[TBL] [Abstract][Full Text] [Related]
9. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
Bury M; Młynarczuk I; Pleban E; Hoser G; Kawiak J; Wójcik C
Folia Histochem Cytobiol; 2001; 39(2):131-2. PubMed ID: 11374791
[TBL] [Abstract][Full Text] [Related]
10. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals).
Lynas JF; Harriott P; Healy A; McKervey MA; Walker B
Bioorg Med Chem Lett; 1998 Feb; 8(4):373-8. PubMed ID: 9871688
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
Kazi A; Daniel KG; Smith DM; Kumar NB; Dou QP
Biochem Pharmacol; 2003 Sep; 66(6):965-76. PubMed ID: 12963483
[TBL] [Abstract][Full Text] [Related]
14. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
Pasquini LA; Besio Moreno M; Adamo AM; Pasquini JM; Soto EF
J Neurosci Res; 2000 Mar; 59(5):601-11. PubMed ID: 10686588
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells.
Drexler HC; Risau W; Konerding MA
FASEB J; 2000 Jan; 14(1):65-77. PubMed ID: 10627281
[TBL] [Abstract][Full Text] [Related]
16. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
Nam S; Smith DM; Dou QP
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol.
Wilk S; Chen WE; Magnusson RP
Arch Biochem Biophys; 1999 Feb; 362(2):283-90. PubMed ID: 9989937
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains.
Kitson RP; Lu M; Siman R; Goldfarb RH
In Vivo; 2000; 14(1):265-8. PubMed ID: 10757085
[TBL] [Abstract][Full Text] [Related]
20. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
